The Effects of Ginger Supplementation on Cardiovascular Risk Factors in Patients with Non-alcoholic Fatty Liver Disease: A Randomised, Double-blind, Placebo-controlled Study

Mehran Rahimlou; Hoda Ahmadnia; Azita Hekmatdoost; Moayed Alavian; Ali Keshavarz;  ;  ;  ;  ;

doi:10.29252/sjimu.25.1.211

The Effects of Ginger Supplementation on Cardiovascular Risk Factors in Patients with Non-alcoholic Fatty Liver Disease: A Randomised, Double-blind, Placebo-controlled Study

journal of ilam university of medical sciences ◽

10.29252/sjimu.25.1.211 ◽

2017 ◽

Vol 25 (1) ◽

pp. 211-219

Author(s):

Mehran Rahimlou ◽

Hoda Ahmadnia ◽

Azita Hekmatdoost ◽

Moayed Alavian ◽

Ali Keshavarz ◽

...

Keyword(s):

Risk Factors ◽

Cardiovascular Risk ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Study ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Alcoholic Fatty Liver Disease

Download Full-text

JKB-122 in subjects with non-alcoholic fatty liver disease (NAFLD): a phase 2, randomized, multiple-dose, double-blind, placebo-controlled study

Journal of Hepatology ◽

10.1016/s0168-8278(20)30779-0 ◽

2020 ◽

Vol 73 ◽

pp. S133

Author(s):

Kuo-Chin Huang ◽

Ming-Yao Chen ◽

Chih-Lin Lin ◽

Sien-Sing Yang ◽

Chao-Wei Hsu ◽

...

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Multiple Dose ◽

Controlled Study ◽

Phase 2 ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Alcoholic Fatty Liver Disease

Download Full-text

Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: A double-blind placebo-controlled study

International Journal of Molecular Medicine ◽

10.3892/ijmm.2013.1503 ◽

2013 ◽

Vol 32 (5) ◽

pp. 989-994 ◽

Cited By ~ 51

Author(s):

RYUICHIRO SAKATA ◽

TORU NAKAMURA ◽

TAKUJI TORIMURA ◽

TAKATO UENO ◽

MICHIO SATA

Keyword(s):

Liver Disease ◽

Liver Function ◽

Fatty Liver ◽

Green Tea ◽

Fatty Liver Disease ◽

Controlled Study ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Alcoholic Fatty Liver Disease

Download Full-text

713 Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease patients: Double-blind placebo-controlled study

Journal of Hepatology ◽

10.1016/s0168-8278(06)80713-0 ◽

2006 ◽

Vol 44 ◽

pp. S262 ◽

Cited By ~ 4

Author(s):

R. Sakata ◽

T. Ueno ◽

T. Nakamura ◽

O. Hashimoto ◽

M. Sakamoto ◽

...

Keyword(s):

Liver Disease ◽

Liver Function ◽

Fatty Liver ◽

Green Tea ◽

Fatty Liver Disease ◽

Controlled Study ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Alcoholic Fatty Liver Disease

Download Full-text

A randomized, double-blind, placebo-controlled study to evaluate the efficacy of a multispecies probiotic mixture in obese non-alcoholic fatty liver disease

Journal of Hepatology ◽

10.1016/s0168-8278(17)31610-0 ◽

2017 ◽

Vol 66 (1) ◽

pp. S592

Author(s):

S.B. Ahn ◽

D.W. Jun ◽

W.K. Saeed ◽

J.S. Lee ◽

Y.J. Chae ◽

...

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Study ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Alcoholic Fatty Liver Disease

Download Full-text

Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

Advances in Therapy ◽

10.1007/s12325-020-01498-5 ◽

2020 ◽

Vol 37 (11) ◽

pp. 4697-4708 ◽

Cited By ~ 3

Author(s):

Hoda Taheri ◽

Mojtaba Malek ◽

Faramarz Ismail-Beigi ◽

Farhad Zamani ◽

Masoudreza Sohrabi ◽

...

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Trial ◽

Liver Steatosis ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Alcoholic Fatty Liver Disease

Download Full-text

Combined cranberry supplementation and weight loss diet in non-alcoholic fatty liver disease: a double-blind placebo-controlled randomized clinical trial

International Journal of Food Sciences and Nutrition ◽

10.1080/09637486.2020.1746957 ◽

2020 ◽

Vol 71 (8) ◽

pp. 991-1000

Author(s):

Razie Hormoznejad ◽

Majid Mohammad Shahi ◽

Fakher Rahim ◽

Bijan Helli ◽

Pezhman Alavinejad ◽

...

Keyword(s):

Clinical Trial ◽

Weight Loss ◽

Liver Disease ◽

Fatty Liver ◽

Randomized Clinical Trial ◽

Fatty Liver Disease ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Alcoholic Fatty Liver Disease

Download Full-text

Review for "Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: a randomised double-blind placebo controlled trial"

10.1111/dom.14129/v1/review4 ◽

2020 ◽

Author(s):

Yang Cao

Keyword(s):

Vitamin D ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Transient Elastography ◽

Controlled Trial ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Alcoholic Fatty Liver Disease

Download Full-text

Review for "Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: a randomised double-blind placebo controlled trial"

10.1111/dom.14129/v3/review2 ◽

2020 ◽

Author(s):

Jay Bae

Keyword(s):

Vitamin D ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Transient Elastography ◽

Controlled Trial ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Alcoholic Fatty Liver Disease

Download Full-text

Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(20)30216-8 ◽

2020 ◽

Vol 5 (11) ◽

pp. 996-1007 ◽

Cited By ~ 2

Author(s):

Takaomi Kessoku ◽

Kento Imajo ◽

Takashi Kobayashi ◽

Anna Ozaki ◽

Michihiro Iwaki ◽

...

Keyword(s):

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Double Blind ◽

Alcoholic Fatty Liver ◽

Double Blind Placebo ◽

Alcoholic Fatty Liver Disease

Download Full-text

The effects of black seed supplementation on cardiovascular risk factors in patients with nonalcoholic fatty liver disease: A randomized, double‐blind, placebo‐controlled clinical trial

Phytotherapy Research ◽

10.1002/ptr.6424 ◽

2019 ◽

Vol 33 (9) ◽

pp. 2369-2377 ◽

Cited By ~ 2

Author(s):

Mina Darand ◽

Zahra Darabi ◽

Zahra Yari ◽

Mehdi Hedayati ◽

Mohammad Amin Shahrbaf ◽

...

Keyword(s):

Risk Factors ◽

Clinical Trial ◽

Cardiovascular Risk ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Controlled Clinical Trial ◽

Double Blind ◽

Nonalcoholic Fatty Liver ◽

Double Blind Placebo

Download Full-text